Medical Monitoring in Clinical Research in 2026: Transformation Toward Intelligent, Risk-Based, and Real-Time Oversight

Abstract

Medical monitoring is undergoing a profound transformation driven by the integration of artificial intelligence (AI), decentralized clinical trials (DCTs), digital health technologies, and the implementation of ICH E6(R3). Traditionally focused on adverse event review and protocol compliance, medical monitoring is increasingly evolving toward a proactive, data-driven, and risk-based governance function. This narrative review explores the emerging role of medical monitors in 2026, highlighting AI-assisted safety surveillance, risk-based quality management, centralized monitoring, predictive analytics, and AI governance frameworks. The review also discusses regulatory expectations, ethical considerations validation requirements, and the continued necessity of medical monitor oversight within increasingly automated clinical ecosystems. Current evidence suggests that AI will augment rather than replace medical monitors, shifting their role from reactive oversight to active anticipation and risk prevention.